Posts

Alexion's Soliris sequence error saga (Alexion v Samsung Bioepis [2025] EWHC 1240)

EPO maintains ST.26 sequence listing requirement for divisionals but compromises on excess page fees

EPO responds to criticism over ST.26 implementation

EPO under fire for its approach to ST.26 sequence listings

ST. 26 sequence listings: A forward or backward step for ease of access to patent sequence data?